Why Pro Medicus Limited is among 4 shares advancing higher today

The Bubs Australia Ltd (ASX:BUB) share price is one of four ending the week strongly. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has followed the lead of international markets and in afternoon trade finds itself down a disappointing 0.8% to 5,730 points.

Four shares which haven't let this hold them back are listed below. Here's why they are finishing the week with a bang:

The Pro Medicus Limited (ASX: PME) share price has climbed 4% to $5.10 after the healthcare software company released its preliminary final results. Despite the impact of currency headwinds, Pro Medicus delivered an impressive 46.4% lift in net profit after tax to $9.3 million. I think this solid result and its positive outlook could mean the company is worth considering as a buy and hold investment.

The Bubs Australia Ltd (ASX: BUB) share price has rebounded from yesterday's heavy decline and is up 6.5% to 65 cents. This morning the baby food and infant formula company announced the appointment of Dennis Lin as Chairman of the Bubs Australia Board. Mr Lin is also a partner at BDO, where he leads the firm's China Advisory Services team. Investors appear to believe this experience will be very useful given Bubs' aim of penetrating the lucrative Chinese infant formula market.

The Kogan.com Ltd (ASX: KGN) share price is up 6% to $2.54 following the release of its full-year results. The online retailer smashed its prospectus forecasts and reported pro forma net profit after tax growth of 800% to $7.2 million. This was driven by a 30% increase in its customer base and strong growth from its private label products.

The Tatts Group Limited (ASX: TTS) share price is up 3.5% to $4.16 thanks partly to a research note out of Deutsche Bank. According to the note, its analysts have retained their buy rating and $4.67 price target following the release of the lottery operator's full-year results. Tatts delivered a result ahead of Deutsche's expectations.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »